Delivery Order 75N91018D00021-75N91022F00001

The National Cancer Institute awarded Kaiser Foundation Hospitals a $1.48 million cost-reimbursable delivery order on April 1, 2022, to sustain an established Participant Advisory Board for the Connect for Cancer Prevention Study. This work falls under a parent Indefinite Delivery Contract titled "Cancer Study Cohort Recruitment" and will be performed in Chicago, Illinois, with an ultimate completion date of March 31, 2027. No small business set-aside was applied to this award, reflecting Kaiser Permanente's established capacity to support complex federal research initiatives.

Kaiser Foundation Hospitals, operating through its Kaiser Foundation Research Institute and doing business as Kaiser Permanente, brings substantial research infrastructure and experience to this engagement. As a major non-profit integrated healthcare system with deep federal research credentials, the organization has demonstrated expertise across numerous National Institutes of Health initiatives, including vaccine safety research, epidemiological studies, and population health investigations. The advisory board support under this delivery order aligns with NCI's cohort recruitment and participant engagement priorities, leveraging Kaiser Permanente's access to large patient populations and established research governance structures to sustain participant involvement in this cancer prevention research initiative.